| Literature DB >> 22934188 |
Ashwini Tilay1, Uday Annapure.
Abstract
Bacterial production of polyunsaturated fatty acids (PUFAs) is a potential biotechnological approach for production of valuable nutraceuticals. Reliable method for screening of number of strains within short period of time is great need. Here, we report a novel simplified method for screening and isolation of PUFA-producing bacteria by direct visualization using the H(2)O(2)-plate assay. The oxidative stability of PUFAs in growing bacteria towards added H(2)O(2) is a distinguishing characteristic between the PUFAs producers (no zone of inhibition) and non-PUFAs producers (zone of inhibition) by direct visualization. The confirmation of assay results was performed by injecting fatty acid methyl esters (FAMEs) produced by selected marine bacteria to Gas Chromatography-Mass Spectrometry (GCMS). To date, this assay is the most effective, inexpensive, and specific method for bacteria producing PUFAs and shows drastically reduction in the number of samples thus saves the time, effort, and cost of screening and isolating strains of bacterial PUFAs producers.Entities:
Year: 2012 PMID: 22934188 PMCID: PMC3426174 DOI: 10.1155/2012/542721
Source DB: PubMed Journal: Biotechnol Res Int ISSN: 2090-3146
Figure 1Proposed mode of action for the H2O2-plate assay method.
Figure 2Map of western coast region of Maharashtra (INDIA).
Figure 3Protocol for primary screening of marine isolates.
Figure 4H2O2-plate assay.
Figure 5Gas chromatogram showing fatty acid profile of a selected marine isolate after primary screening.
Fatty acid profile of marine isolate produced after fermentation in secondary screening.
| Fatty acid methyl esters (MUFA + PUFA) | Selected strains for secondary screening and their fatty acid profile | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| M BB 318 | BB 83 | ALI B 51 | BB 227 | MD BB 345 | BB 198 | DIG BB 4 | TAV B 27 | TH BB 19 | TH BB 21 | |
| Pentadecanoic acid |
|
|
|
|
|
|
|
|
|
|
| Hexadecanoic acid |
|
|
|
|
|
|
|
|
|
|
| 14-methylhexadecanoate |
|
|
|
|
|
|
|
|
|
|
| Margaric acid |
|
|
|
|
|
|
|
|
|
|
| Oleic acid |
|
|
|
|
|
|
|
|
|
|
| 16-Octadecenoic acid |
|
|
|
|
|
|
|
|
|
|
| 7,10-Octadecadienoic acid |
|
|
|
|
|
|
|
|
|
|
| Linoleic acid |
|
|
|
|
|
|
|
|
|
|
| 7,10,13-Hexadecatrienoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Linolenic acid |
|
|
|
|
|
|
|
|
|
|
| Eicosanoic acid |
|
|
|
|
|
|
|
|
|
|
| Arachidonic acid |
|
|
|
|
|
|
|
|
|
|
| Eicosapentaenoic acid |
|
|
|
|
|
|
|
|
|
|
Note: MUFA- monounsaturated fatty acid.
(a)
| No. | Strain | H2O2 @ (%) | PUFA* | No. | Strain | H2O2 @ (%) | PUFA* | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 0.5 | 1.0 | +ve/−ve | 0.1 | 0.5 | 1.0 | +ve/−ve | ||||
| 1 | JAY B 8 | − | − | − | −ve | 26 | TH B 9 | − | − | − | −ve |
| 2 | TAV B 31 | − | − | − | −ve | 27 | DI BB 152 | − | − | + | +ve |
| 3 | PA BB 8 | − | − | − | −ve | 28 |
|
|
|
|
|
| 4 | TH BB 31 | − | − | − | −ve | 29 | ALI B 71 | − | − | − | −ve |
| 5 | DIG BB 113 | − | − | − | −ve | 30 | R BB 11 | + | + | − | +ve |
| 6 | TH BB 22 | − | − | − | −ve | 31 | BB 82 | − | − | − | −ve |
| 7 | PA BB 3 | − | − | − | −ve | 32 | JAY B 12 | − | − | − | −ve |
| 8 | TH BB 15 | − | − | − | −ve | 33 | TH BB 22 | − | − | − | −ve |
| 9 | P BB 13 | − | − | − | −ve | 34 | MAN BB 358 | − | − | − | −ve |
| 10 |
|
|
|
|
| 35 | P BB 9 | − | − | − | −ve |
| 11 |
|
|
|
|
| 36 | TH 33 | − | − | − | −ve |
| 12 | DI BB 146 | − | − | + | +ve | 37 | R 23 | − | − | − | −ve |
| 13 | GP B 2 | − | + | ++ | +ve | 38 | RAT B 18 | − | − | − | −ve |
| 14 | AH B 53 | − | + | ++ | +ve | 39 | RA 21 | − | − | − | −ve |
| 15 |
|
|
|
|
| 40 | MD BB 325 | − | − | − | −ve |
| 16 | PA BB 8 | − | + | ++ | +ve | 41 | SHI BB 2 | − | − | − | −ve |
| 17 | TH BB 5 | − | + | + | +ve | 42 | PA B 12 | − | − | − | −ve |
| 18 | MAN BB 200 | − | − | − | −ve | 43 | PA BB 4 | − | − | − | −ve |
| 19 | MAN BB 361 | − | − | − | −ve | 44 | TH BB 27 | − | − | − | −ve |
| 20 | AL BB 156 | − | + | ++ | +ve | 45 | TH BB 25 | − | − | − | −ve |
| 21 | TH BB 20 | − | + | ++ | +ve | 46 |
|
|
|
|
|
| 22 |
|
|
|
|
| 47 | TH BB 30 | − | − | − | −ve |
| 23 |
|
|
|
|
| 48 | MAN 10 | − | − | − | −ve |
| 24 | BB 232 | − | + | + | +ve | 49 | BB 72 | − | − | − | −ve |
| 25 | MAN 353 | − | − | + | +ve | 50 | R 37 | − | − | − | −ve |
@describes zone of inhibition due to presence H2O2; +/++ describes growth of microorganisms or no zone of inhibition due to presence of PUFA.
*PUFA +ve denotes PUFA producer and −ve denotes PUFA nonproducer.
Note: highlighted strains were further screened by secondary analysis.
(b)
| No. | Strain | H2O2 @ (%) | PUFA* | No. | Strain | H2O2 @ (%) | PUFA* | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 0.5 | 1.0 | +ve/−ve | 0.1 | 0.5 | 1.0 | +ve/−ve | ||||
| 51 |
|
|
|
|
| 76 | MD BB 312 | − | − | − | −ve |
| 52 |
|
|
|
|
| 77 | MAN BB 63 | − | − | − | −ve |
| 53 | RAT B 3 | − | − | − | −ve | 78 | TH BB 28 | − | − | − | −ve |
| 54 | AK BB 189 | − | − | − | −ve | 79 | JAY B 38 | − | − | − | −ve |
| 55 | BB 201 | − | − | − | −ve | 80 | BB 20 | + | − | − | +ve |
| 56 | MAN 352 | − | − | − | −ve | 81 | P BB 22 | − | − | − | −ve |
| 57 | TH 33 | + | − | − | +ve | 82 | RAT B 85 | − | − | − | −ve |
| 58 |
|
|
|
|
| 83 | SHI BB 2 | − | − | − | −ve |
| 59 | R 13 | − | − | − | −ve | 84 | PA BB 33 | − | − | − | −ve |
| 60 | HAR BB 118 | − | − | − | −ve | 85 | MD BB 122 | − | − | − | −ve |
| 61 | RO BB 24 | + | − | − | +ve | 86 | MAN BB 229 | + | − | − | +ve |
| 62 | TH BB 24 | − | − | − | −ve | 87 | TH BB 82 | − | − | − | −ve |
| 63 | SRK 6 | − | − | − | −ve | 88 | DIG BB 122 | − | − | − | −ve |
| 64 | BB 245 | − | − | − | −ve | 89 | G BB 89 | − | − | − | −ve |
| 65 | BB 86 | − | − | − | −ve | 90 | MAN 63 | − | − | − | −ve |
| 66 | G BB 249 | − | − | − | −ve | 91 | AL BB 148 | − | − | − | −ve |
| 67 | DIG BB 108 | − | − | − | −ve | 92 | TAV B 47 | − | − | − | −ve |
| 68 | MD BB 338 | − | − | − | −ve | 93 | R 39 | − | − | − | −ve |
| 69 | TH BB 166 | − | − | − | −ve | 94 | BB 289 | + | − | − | +ve |
| 70 | MAN BB 364 | − | − | − | −ve | 95 | JAY B 23 | − | − | − | −ve |
| 71 | SRK 23 | − | − | − | −ve | 96 | DI BB 278 | − | − | − | −ve |
| 72 | TH BB 83 | − | − | − | −ve | 97 | TH B 34 | − | − | − | −ve |
| 73 | BB 39 | − | − | − | −ve | 98 | AK BB 148 | − | − | − | −ve |
| 74 | TAV B 29 | − | − | − | −ve | 99 | HAR BB 72 | − | − | − | −ve |
| 75 | SHE BB 29 | − | − | − | −ve | 100 | RO BB 41 | − | − | − | −ve |
@describes zone of inhibition due to presence H2O2; +/++ describes growth of microorganisms or no zone of inhibition due to presence of PUFA.
*PUFA +ve denotes PUFA producer and −ve denotes PUFA nonproducer.
Note: highlighted strains were further screened by secondary analysis.